StartUp Health Moonshots, LP - C2 is a venture capital fund based in Seattle, Washington. According to its most recent Form D, filed Jul 21, 2023, it has sold $506,412 of interests to 23 investors since its first sale in Jul 2023. The minimum investment it accepts from an outside investor is $2,465. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Ltd. Belltower Fund Group; LLC Fund GP.
- Total raised
- $506,412Cumulative sales reported on Form D
- Investors
- 23
- First sale
- Jul 10, 2023
- Minimum investment
- $2,465
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- Ltd. Belltower Fund Group; LLC Fund GP
- Latest Form D
- Jul 21, 2023
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Related vehicles with the same name (11)
| Vehicle | Total raised | Investors | Latest Form D |
|---|---|---|---|
| StartUp Health Moonshots, LP - A3 | $1,511,365 | 46 | Nov 15, 2021 |
| StartUp Health Moonshots, LP - A4 | $1,496,250 | 49 | Jan 11, 2022 |
| StartUp Health Moonshots, LP - B1 | $1,208,750 | 46 | Apr 8, 2022 |
| StartUp Health Moonshots, LP - A2 | $940,000 | 29 | Jul 16, 2021 |
| StartUp Health Moonshots, LP - B3 | $831,250 | 39 | Oct 11, 2022 |
| StartUp Health Moonshots, LP - A1 | $830,000 | 23 | Jun 25, 2021 |
| StartUp Health Moonshots, LP - B2 | $741,250 | 35 | Jul 5, 2022 |
| StartUp Health Moonshots, LP - B4 | $646,250 | 33 | Jan 19, 2023 |
| StartUp Health Moonshots, LP - C1 | $566,507 | 36 | May 5, 2023 |
| StartUp Health Moonshots, LP - C2 (this page) | $506,412 | 23 | Jul 21, 2023 |
| StartUp Health Moonshots, LP - C3 | $213,750 | 9 | Oct 11, 2023 |
Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 11 filings share this fund's name apart from such vehicle words or a series letter, which usually means they are versions of one fund. Grouped by AltMountain from the names on the filings alone, so the list may be incomplete or include a separate fund with a near-identical name; amounts are each vehicle's own filing and should not be added together, because a feeder's money can also be counted in its master fund. Source: SEC Form D filings.
Questions about StartUp Health Moonshots, LP - C2
What is the minimum investment for StartUp Health Moonshots, LP - C2?
According to its latest Form D, filed Jul 21, 2023, the minimum investment StartUp Health Moonshots, LP - C2 accepts from an outside investor is $2,465.
Who can invest in StartUp Health Moonshots, LP - C2?
StartUp Health Moonshots, LP - C2 is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has StartUp Health Moonshots, LP - C2 raised?
StartUp Health Moonshots, LP - C2 reports $506,412 sold from 23 investors on its Form D filed Jul 21, 2023. This is cumulative sales since the offering began, not current assets or performance.
Where is StartUp Health Moonshots, LP - C2 based?
StartUp Health Moonshots, LP - C2 is based in Seattle, Washington.
When did StartUp Health Moonshots, LP - C2 launch?
StartUp Health Moonshots, LP - C2 reports its first sale in Jul 2023.
Size compared with every venture capital fund
Raised more than 72% of the 5,438 venture capital funds based in Washington, and more than 49% of all 14,901 that report sales.